NCT06066372 Application of Machine Learning Models to Reduce Need for Diagnostic EUS or MRCP in Patients With Intermediate Likelihood of Choledocholithiasis
| NCT ID | NCT06066372 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Asian Institute of Gastroenterology, India |
| Condition | Choledocholithiasis |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2023-10-01 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2023-10-01 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Machine learning predictive model can help in stratifying heterogenous intermediate likelihood group to reduce need for EUS or MRCP in selected subgroup of patients.
Eligibility Criteria
Inclusion Criteria: • Individual 18 years or older with a suspected choledocholithiasis satisfying either ASGE or ESGE risk stratification criteria of intermediate likelihood undergoing EUS or MRCP Exclusion Criteria: * Patients having co-exiting disease of pancreato biliary system other than gall stones and choledocholithiasis which include chronic pancreatitis, biliary stricture, pancreatobiliary malignancy, portal biliopathy * Patients having underlying chronic liver diseases * Pregnancy and breast feeding * Previous history of cholecystectomy
Contact & Investigator
Mohan Ramchandani, MD
STUDY DIRECTOR
Asian Institute of Gastroenterology
Frequently Asked Questions
Who can join the NCT06066372 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Choledocholithiasis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06066372 currently recruiting?
Yes, NCT06066372 is actively recruiting participants. Contact the research team at docnits13@gmail.com for enrollment information.
Where is the NCT06066372 trial being conducted?
This trial is being conducted at Hyderabad, India.
Who is sponsoring the NCT06066372 clinical trial?
NCT06066372 is sponsored by Asian Institute of Gastroenterology, India. The principal investigator is Mohan Ramchandani, MD at Asian Institute of Gastroenterology. The trial plans to enroll 1,000 participants.